Search research articles
Contact Us
Filters
Showing results (791-800 of 828) with videos related to
Page
of 83
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
May 20, 2024
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies
Kirk D Beebe, Joel R Eisner, John Guo, et al.
Journal for Immunotherapy of Cancer
|
April 5, 2025
Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancers
Manpreet Kaur, Katja Rüger, Elaine C Chen, et al.
Human Pathology
|
June 14, 2014
GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival
Aatur D Singhi, Jon M Davison, Haroon A Choudry, et al.
Plos One
|
November 14, 2013
Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium
Usha Malhotra, Ali H Zaidi, Juliann E Kosovec, et al.
Clinical and Translational Gastroenterology
|
August 25, 2023
A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's Esophagus
Jon M Davison, John R Goldblum, Lucas C Duits, et al.
The American Journal of Surgical Pathology
|
October 22, 2013
Appropriate use of special stains for identifying Helicobacter pylori: Recommendations from the Rodger C. Haggitt Gastrointestinal Pathology Society
Kenneth P Batts, Scott Ketover, Sanjay Kakar, et al.
Cancer
|
August 8, 2014
Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma
Ali H Zaidi, Vanathi Gopalakrishnan, Pashtoon M Kasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 26, 2024
Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
Joel R Eisner, Florus C de Jong, Yoichiro Shibata, et al.
Gut
|
November 11, 2017
Guidelines on the management of abnormal liver blood tests
Philip N Newsome, Rob Cramb, Suzanne M Davison, et al.
International Journal of Cancer
|
April 20, 2019
High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma
Jorge L Sepulveda, Elena V Komissarova, Sarawut Kongkarnka, et al.
Page
of 83
Search research articles
Search
Showing results (791-800 of 828) with videos related to
Sort By:
Page
of 83
Journal of Immunology (Baltimore, Md. : 1950)
|
May 20, 2024
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies
Kirk D Beebe, Joel R Eisner, John Guo, et al.
Journal for Immunotherapy of Cancer
|
April 5, 2025
Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancers
Manpreet Kaur, Katja Rüger, Elaine C Chen, et al.
Human Pathology
|
June 14, 2014
GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival
Aatur D Singhi, Jon M Davison, Haroon A Choudry, et al.
Plos One
|
November 14, 2013
Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium
Usha Malhotra, Ali H Zaidi, Juliann E Kosovec, et al.
Clinical and Translational Gastroenterology
|
August 25, 2023
A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's Esophagus
Jon M Davison, John R Goldblum, Lucas C Duits, et al.
The American Journal of Surgical Pathology
|
October 22, 2013
Appropriate use of special stains for identifying Helicobacter pylori: Recommendations from the Rodger C. Haggitt Gastrointestinal Pathology Society
Kenneth P Batts, Scott Ketover, Sanjay Kakar, et al.
Cancer
|
August 8, 2014
Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma
Ali H Zaidi, Vanathi Gopalakrishnan, Pashtoon M Kasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 26, 2024
Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
Joel R Eisner, Florus C de Jong, Yoichiro Shibata, et al.
Gut
|
November 11, 2017
Guidelines on the management of abnormal liver blood tests
Philip N Newsome, Rob Cramb, Suzanne M Davison, et al.
International Journal of Cancer
|
April 20, 2019
High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma
Jorge L Sepulveda, Elena V Komissarova, Sarawut Kongkarnka, et al.
Page
of 83